Combination therapy using coenzyme Q10 and a caffeic acid-derived ester
US9040579B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 18, 2011 |
| Grant date | May 26, 2015 |
| Priority date | — |
| Expiry date | Feb 27, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition containing a mitochondrial electron transport chain enhancer (or an antioxidant) and a compound of formula (I) shown in the specification. This pharmaceutical composition can be used to treat neurodegenerative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.